BEVILACQUA, GENEROSO
 Distribuzione geografica
Continente #
NA - Nord America 23.730
EU - Europa 8.182
AS - Asia 3.803
SA - Sud America 184
AF - Africa 157
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 36.073
Nazione #
US - Stati Uniti d'America 18.618
CA - Canada 5.106
IT - Italia 2.117
CN - Cina 2.104
PL - Polonia 1.665
SE - Svezia 1.279
BG - Bulgaria 785
SG - Singapore 689
DE - Germania 590
TR - Turchia 491
UA - Ucraina 489
FI - Finlandia 339
GB - Regno Unito 319
VN - Vietnam 287
CH - Svizzera 170
BR - Brasile 163
RU - Federazione Russa 148
HK - Hong Kong 87
AT - Austria 82
IN - India 80
CI - Costa d'Avorio 79
BE - Belgio 61
FR - Francia 44
SN - Senegal 41
NL - Olanda 26
BJ - Benin 19
CZ - Repubblica Ceca 12
IE - Irlanda 12
PK - Pakistan 12
AU - Australia 10
ES - Italia 9
AR - Argentina 7
GR - Grecia 7
JP - Giappone 7
NG - Nigeria 7
RO - Romania 7
BD - Bangladesh 6
IQ - Iraq 6
DK - Danimarca 5
TW - Taiwan 5
AZ - Azerbaigian 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
TN - Tunisia 4
UZ - Uzbekistan 4
VE - Venezuela 4
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
NZ - Nuova Zelanda 3
EC - Ecuador 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
MX - Messico 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
ID - Indonesia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MY - Malesia 1
NA - Namibia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 36.073
Città #
Montreal 4.590
Woodbridge 2.876
Ann Arbor 2.135
Fairfield 1.761
Houston 1.607
Chandler 1.431
Ashburn 1.057
Santa Clara 823
Sofia 785
Seattle 755
Milan 715
Wilmington 663
Jacksonville 628
Cambridge 627
Shanghai 547
Beijing 512
Ottawa 496
New York 459
Singapore 368
Izmir 341
Princeton 336
Boardman 326
Nanjing 306
Lawrence 302
Medford 285
Des Moines 225
Serra 193
Bern 170
Dearborn 160
Florence 143
Istanbul 128
Dong Ket 123
Nanchang 111
Jüchen 101
Pisa 101
San Diego 90
Hong Kong 85
Falls Church 84
Abidjan 79
Vienna 78
Kunming 65
Redwood City 62
Frankfurt am Main 61
Ogden 61
Boulder 60
Rome 59
Shenyang 54
Brussels 53
Washington 52
Changsha 46
Dakar 41
Hebei 41
Hefei 40
Lancaster 40
Tianjin 38
Pune 37
Norwalk 36
Bremen 33
London 33
Jiaxing 30
Auburn Hills 29
Orange 29
Alessandria 28
Düsseldorf 25
Fuzhou 24
Indiana 21
Los Angeles 21
Grafing 20
Cotonou 19
Guangzhou 19
Hangzhou 19
Detroit 18
São Paulo 18
Dallas 17
Nürnberg 17
Verona 17
Jinan 16
Kocaeli 15
Lucca 15
Lanzhou 14
Quanzhou 13
Changchun 12
Tappahannock 11
Wuhan 11
Capannori 10
Phoenix 10
Quarrata 10
San Francisco 10
Chicago 9
Dublin 8
Toronto 8
Xiamen 8
Agugliano 7
Council Bluffs 7
Lagos 7
Sacile 7
Waanrode 7
Zhengzhou 7
Amsterdam 6
Golders Green 6
Totale 28.119
Nome #
CORRELATION OF GENE EXPRESSION PROFILES WITH CLINICAL RESPONSE TO GEMCITABINE IN PANCREATIC CANCER 3.251
CANCER RISK AMONG THE RELATIVES OF PROBANDS WITH PANCEATIC DUCTAL ADENOCARCINOMA 3.180
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 199
Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. 183
Unusual findings of viral production (MuMTV) in murine mammary tumors (BALB/cfC3H). 176
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 175
Stromal tumours : which diagnostic approach? 168
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). 160
Cytogenesis of murine mammary tumors in BALB/cfC3H and BALB/cfRIII strains. 159
Ultrastructural features of the intestinal absorption of mouse mammary tumor virus in newborn BALB/cfRIII mice. 159
Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in italian BRCA 1/2 carriers 156
Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. 155
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program 154
Spontaneous dissecting aneurysm of the aorta in a dog. 152
Sparc-like protein 1 is a new marker of human glioma progression 152
Variability of the expression of muscle mitochondrial damage in ocular mitochondrial myopathy. 151
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine 149
Choroid Plexus carcinoma: a new case associated with a novel TP53 germ line mutation 148
Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus 148
Histones of human lung carcinoma and human lung tissue. Analysis by two-dimensional electrophoresis. 147
Development of combined DNA-based piezoelectric biosensors for the simultaneous detection and genotyping of high risk Human Papilloma Virus strains 147
c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules. 145
Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family. 144
A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma 144
Feline immunodeficiency virus vector as a tool for preventative strategies against human breast cancer 143
Tumor cell heterogeneity and metastasis. 142
VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma. 142
Effects of primary chemotherapy on biological parameters of locally advanced breast cancer. 141
A new microwave scanning system for imaging superficial organs. 140
Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers 140
Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. 140
Cellular Transfection Evidence in Pancreatic Tumor Primary Cell Cultures Through Electroporation of Green Fluorescent Protein (GFP) 139
Quantitative determination of mammary tumor virus in individual samples of mouse milk. 138
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 138
A renin-secreting tumor 138
Absence of somatic mutations in the coding region of the WAF1/CIP1 gene in human breast, lung and ovarian carcinomas. A polymorphism at codon 31 138
Endothelial progenitor cells recruitment correlate with coronary artery disease severity 138
Association between RAD 51 rs1801320 and susceptibility to glioblastoma 137
Tumor targeting potential and metabolism of 5-(125-I)-Iodo-2’-Deoxyuridine injected intratumorally in patients with breast cancer. 136
Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer. 136
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers 136
Metastatic cervical carcinoma presenting as primary thyroid cancer. Case report. 135
Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas 135
Aspetti istologici della erosione e della riapposizione ossea nel colesteatoma otomastoideo infiltrante del bambino 132
A case of cavernous haemangioma of the spleen. 132
Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples 131
Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications 131
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype 131
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 131
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. 130
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma 130
Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells 130
A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers 130
Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: New emerging cancer players 130
Presence of endothelin-1 in the normal and pathological human thyroid. 129
Evaluation of FHIT gene alterations in ovarian cancer 128
Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo. 128
Papillary lesions of the breast: a molecular progression? 127
Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. 127
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations 126
Bone marrow necrosis foreshadowing acute lymphoid leukemia. 126
p53 nuclear accumulation in adenomatous hyperplasia and stage I endometrioid carcinoma. 125
Homozygosis Mutation in K-ras Oncogene in Primary Cell Culture from Pancreatic Ductal Adenocarcinoma. Characteristic of the Tumor or Adaptation in Vitro? 125
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients 125
The Stem Cell Factor-c-kit System and Mast Cells in Human Pancreatic Cancer 124
Clinicopathological significance of GADD45 gene alterations in human familial breast carcinoma 124
Ocular myopathy without ophthalmoplegia can be a form of mitochondrial myopathy. 124
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 124
Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases 123
p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations 123
Cell cycle regulators in lung cancer 122
A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function 122
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 122
Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules 122
CARDIAC TOXICITY AND ANTITUMOR-ACTIVITY OF 4'-DEOXY-4'-IODO-DOXORUBICINOL 122
Tumor targeting in vivo and metabolic fate of 5-(Iodine-125)-Iodo-2’- Deoxyuridine following intratumoral injection in patients with colorectal cancer. 121
RNA based analysis of BRCA and BRCA gene alterations 121
Bio-morphological events in the development of the human female mammary gland from fetal age to puberty 121
Apocrine epithelium of the breast: does it result from metaplasia? 121
Genes involved in gemcitabine activity: pancreas cancer vs primary cell cultures 120
mdm2 gene alterations and mdm2 protein expression in breast carcinomas 120
3'-Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): a new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity. 120
Ganglioglioma of the spinal cord. A case with a long survival. 119
Identification and characterization of differentially expressed genes in tumor metastasis: the nm23 gene. 119
Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells 119
Histopathologic Analysis of Peritumoral Pseudocapsule and Surgical Margin Status after Tumor Enucleation for Renal Cell Carcinoma 119
Microvessel density in human normal and neoplastic parathyroids 119
Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma 119
mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. 119
Collagenase distension, two-step sequential filtration, and histopaque gradient purification for consistent isolation of pure pancreatic islets from the market-age (6-month-old) pig 119
Adenocarcinoma in the mummy of Ferrante I of Aragon, King of Naples (1431-1494) 119
A low NM23.H1 gene expression identifyjng high malignancy human melanomas. 118
Genetic alterations in hereditary breast cancer 118
Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. 118
Neoangiogenesis as prognostic indicator of survival in lung cancer. 117
Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology 117
Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. 116
NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. 116
Insulin-like growth factor II (IGF-II) immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters 116
Different expressivity of brca1 and brca2: analysis of 179 italian pedigrees with identified mutation 114
Totale 19.555
Categoria #
all - tutte 83.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.139 0 0 0 0 0 0 563 369 486 254 389 78
2020/20212.118 202 97 189 82 259 86 141 239 166 194 120 343
2021/20223.393 57 195 53 290 649 478 67 185 170 128 135 986
2022/20233.757 502 391 256 394 409 575 33 274 553 21 299 50
2023/20249.191 440 347 392 172 481 595 73 47 56 6.274 62 252
2024/20252.903 18 350 74 547 781 726 407 0 0 0 0 0
Totale 36.345